Erratum: Targeting ceramide synthase 6–dependent metastasis-prone phenotype in lung cancer cells(Journal of Clinical Investigation(2016)126: (1()254–265)Doi:10.1172/JCI79775);Targeting ceramide synthase 6-dependent metastasisprone phenotype in lung cancer cells

Journal of Clinical Investigation

Volumn 126, Issue 1, 2016, Pages 254-265

  Suzuki, Motoshi ^a   Cao, Ke ^a,j   Kato, Seiichi ^b   Komizu, Yuji ^c   Mizutani, Naoki ^d   Tanaka, Kouji ^d   Arima, Chinatsu ^a   Chee Tai, Mei ^a   Yanagisawa, Kiyoshi ^a   Togawa, Norie ^a   Shiraishi, Takahiro ^a   Usami, Noriyasu ^a   Taniguchi, Tetsuo ^a   Fukui, Takayuki ^a   Yokoi, Kohei ^a   Wakahara, Keiko ^a   Hasegawa, Yoshinori ^a   Mizutani, Yukiko ^e   Igarashi, Yasuyuki ^e   Inokuchi, Jin Ichi ^f   Iwaki, Soichiro ^g   Fujii, Satoshi ^g   Satou, Akira ^b   Matsumoto, Yoko ^c   Ueoka, Ryuichi ^c   Tamiya Koizumi, Keiko ^d   Murate, Takashi ^d   Nakamura, Mitsuhiro ^h   Kyogashima, Mamoru ⁱ   Takahashi, Takashi ^a   more..

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c SOJO UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

^f TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^g NAGOYA CITY UNIVERSITY   (Japan)

^h GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

ⁱ NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

^j THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; CERAMIDE SYNTHASE 6; DIMYRISTOYLPHOSPHATIDYLCHOLINE; MICRORNA 101; SYNTHETASE; UNCLASSIFIED DRUG; CERS6 PROTEIN, HUMAN; MEMBRANE PROTEIN; MICRORNA; MIRN101 MICRORNA, HUMAN; SPHINGOSINE ACYLTRANSFERASE;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CELL DEATH; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; TUMOR INVASION; TUMOR REGRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; CARCINOMA, NON-SMALL-CELL LUNG; DRUG EFFECTS; GENETICS; LUNG NEOPLASMS; MALE; METABOLISM; METASTASIS; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CERAMIDES; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MICE; MICRORNAS; NEOPLASM METASTASIS; PHENOTYPE; SPHINGOSINE N-ACYLTRANSFERASE;

EID: 84956617449     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI133806     Document Type: Erratum

References (46)

1. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4(8):604-616.
2. Hannun YA, Obeid LM. Many ceramides. J Biol Chem. 2011;286(32):27855-27862.
3. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science. 1993;259(5102):1769-1771.
4. Thomas RL Jr, Matsko CM, Lotze MT, Amoscato AA. Mass spectrometric identification of increased C16 ceramide levels during apoptosis. J Biol Chem. 1999;274(43):30580-30588.
5. Grosch S, Schiffmann S, Geisslinger G. Chain length-specific properties of ceramides. Prog Lipid Res. 2012;51(1):50-62.
6. Karahatay S, et al. Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett. 2007;256(1):101-111.
7. Erez-Roman R, Pienik R, Futerman AH. Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression. Biochem Biophys Res Commun. 2010;391(1):219-223.
8. Senkal CE, Ponnusamy S, Bielawski J, Hannun YA, Ogretmen B. Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways. FASEB J. 2010;24(1):296-308.
9. Takeuchi T, et al. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol. 2006;24(11):1679-1688.
10. Tomida S, et al. Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. J Clin Oncol. 2009;27(17):2793-2799.
11. Huang QM, Akashi T, Masuda Y, Kamiya K, Takahashi T, Suzuki M. Roles of POLD4, smallest subunit of DNA polymerase delta, in nuclear structures and genomic stability of human cells. Biochem Biophys Res Commun. 2010;391(1):542-546.
12. Huang QM, et al. Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer. Cancer Res. 2010;70(21):8407-8416.
13. Mizutani Y, Kihara A, Igarashi Y. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem J. 2005;390(pt 1):263-271.
14. Osada H, Takahashi T. let-7 and miR-17-92: small-sized major players in lung cancer development. Cancer Sci. 2011;102(1):9-17.
15. Xiao H, Liu M. Atypical protein kinase C in cell motility. Cell Mol Life Sci. 2013;70(17):3057-3066.
16. Krishnamurthy K, Wang G, Silva J, Condie BG, Bieberich E. Ceramide regulates atypical PKCzeta/lambda-mediated cell polarity in primitive ectoderm cells. A novel function of sphingolipids in morphogenesis. J Biol Chem. 2007;282(5):3379-3390.
17. Wang G, Krishnamurthy K, Bieberich E. Regulation of primary cilia formation by ceramide. J Lipid Res. 2009;50(10):2103-2110.
18. Wang G, Krishnamurthy K, Umapathy NS, Verin AD, Bieberich E. The carboxyl-terminal domain of atypical protein kinase Czeta binds to ceramide and regulates junction formation in epithelial cells. J Biol Chem. 2009;284(21):14469-14475.
19. Zeidan YH, Jenkins RW, Hannun YA. Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ ceramide pathway. J Cell Biol. 2008;181(2):335-350.
20. Lacour S, et al. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res. 2004;64(10):3593-3598.
21. Cao K, et al. Hybrid liposomes affect cellular lipid constituents and caveolae structures. Bioorg Med Chem Lett. 2012;22(4):1731-1733.
22. Matsumoto Y, Iwamoto Y, Matsushita T, Ueoka R. Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells. Int J Cancer. 2005;115(3):377-382.
23. Santana P, et al. Acid sphingomyelinasedeficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 1996;86(2):189-199.
24. Jimbo M, et al. Development of a new inhibitor of glucosylceramide synthase. J Biochem. 2000;127(3):485-491.
25. Xu XY, Pei F, You JF. TMSG-1 and its roles in tumor biology. Chin J Cancer. 2010;29(7):697-702.
26. Wang H, et al. Expression and prognostic significance of a new tumor metastasis suppressor gene LASS2 in human bladder carcinoma. Med Oncol. 2012;29(3):1921-1927.
27. Thu KL, Chari R, Lockwood WW, Lam S, Lam WL. miR-101 DNA copy loss is a prominent subtype specific event in lung cancer. J Thorac Oncol. 2011;6(9):1594-1598.
28. Varambally S, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science. 2008;322(5908):1695-1699.
29. Chen S, Wang H, Ng WL, Curran WJ, Wang Y. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level. Int J Radiat Oncol Biol Phys. 2011;81(5):1524-1529.
30. Edmond V, et al. Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility. Oncogene. 2015;34(8):996-1005.
31. Inokuchi J, Radin NS. Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase. J Lipid Res. 1987;28(5):565-571.
32. Jonkers J, Berns A. Oncogene addiction: sometimes a temporary slavery. Cancer Cell. 2004;6(6):535-538.
33. Krause DS, Van Etten RA. Tyrosine kinases as targets for cancer therapy. N Engl J Med. 2005;353(2):172-187.
34. Kozaki K, Miyaishi O, Tsukamoto T, Tatematsu Y, Hida T, Takahashi T. Establishment and characterization of a human lung cancer cell line NCIH460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res. 2000;60(9):2535-2540.
35. Hayashita Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005;65(21):9628-9632.
36. Ichihara H, Hino M, Umebayashi M, Matsumoto Y, Ueoka R. Intravenous injection of hybrid liposomes suppresses the liver metastases in xenograft mouse models of colorectal cancer in vivo. Eur J Med Chem. 2012;57:143-148.
37. Abe A, et al. Improved inhibitors of glucosylceramide synthase. J Biochem. 1992;111(2):191-196.
38. Nakano K, Iwamoto Y, Takata W, Matsumoto Y, Ueoka R. Specific accumulation and growth inhibitory effects of hybrid liposomes to hepatoma cells in vitro. Bioorg Med Chem Lett. 2002;12(22):3251-3254.
39. Ichihara H, Nagami H, Kiyokawa T, Matsumoto Y, Ueoka R. Chemotherapy using hybrid liposomes along with induction of apoptosis. Anticancer Res. 2008;28(2B):1187-1195.
40. Inokuchi J, Mason I, Radin NS. Antitumor activity via inhibition of glycosphingolipid biosynthesis. Cancer Lett. 1987;38(1-2):23-30.
41. Matsubara H, et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p miR-20a in lung cancers overexpressing miR-17-92. Oncogene. 2007;26(41):6099-6105.
42. Ebi H, et al. Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancer. Cancer Res. 2007;67(23):11158-11165.
43. Hosono Y, et al. MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis. EMBO J. 2012;31(2):481-493.
44. Tokumaru S, Suzuki M, Yamada H, Nagino M, Takahashi T. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis. 2008;29(11):2073-2077.
45. Kasumov T, Huang H, Chung YM, Zhang R, McCullough AJ, Kirwan JP. Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Biochem. 2010;401(1):154-161.
46. Arima C, et al. Lung adenocarcinoma subtypes definable by lung development-related miRNA expression profiles in association with clinicopathologic features. Carcinogenesis. 2014;35(10):2224-2231.